SCN3A Gene Epilepsy Focal SCN3A Related NGS Genetic DNA Test
Comprehensive Genetic Testing for Neurological Disorders
The SCN3A Gene Epilepsy Focal SCN3A Related NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, specifically designed to identify mutations in the SCN3A gene that are associated with focal epilepsy and related neurological conditions. This advanced testing methodology provides crucial insights for patients and healthcare providers seeking to understand the genetic basis of seizure disorders.
What Does This Test Measure?
This sophisticated genetic analysis specifically targets the SCN3A gene, which encodes the sodium channel protein Nav1.3. Mutations in this gene can disrupt normal neuronal function and lead to various forms of epilepsy, particularly focal seizures that originate in specific brain regions. The test utilizes next-generation sequencing technology to comprehensively analyze the entire SCN3A gene, detecting:
- Point mutations and single nucleotide variants
- Small insertions and deletions
- Copy number variations
- Pathogenic variants associated with epilepsy syndromes
Who Should Consider This Test?
This genetic test is particularly valuable for individuals experiencing:
- Unexplained focal seizures or epilepsy
- Developmental delays with seizure activity
- Family history of epilepsy or neurological disorders
- Resistance to conventional anti-epileptic medications
- Early-onset seizure disorders without clear cause
- Neurological symptoms accompanied by cognitive impairment
Key Benefits of SCN3A Genetic Testing
Undergoing this comprehensive genetic analysis provides numerous advantages for patients and their families:
- Precise Diagnosis: Accurate identification of SCN3A mutations enables targeted treatment approaches
- Personalized Treatment: Results can guide medication selection and management strategies
- Genetic Counseling: Provides essential information for family planning and genetic risk assessment
- Early Intervention: Facilitates timely management of neurological symptoms
- Research Contribution: Helps advance understanding of epilepsy genetics
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our team of neurological genetics specialists. Positive results indicating SCN3A mutations provide valuable information for treatment planning and family counseling. Negative results help exclude this specific genetic cause, allowing healthcare providers to explore other potential factors. All results come with comprehensive explanations and recommendations for next steps, including consultation with neurologists and genetic counselors.
Test Pricing Information
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We provide comprehensive genetic testing services across the United States, with convenient locations in major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure accurate and reliable results for patients nationwide.
Schedule Your Genetic Test Today
Take the first step toward understanding your neurological health with our advanced SCN3A genetic testing. Our experienced team is ready to assist you with scheduling, sample collection, and result interpretation. Contact us today to book your appointment and begin your journey toward precise genetic diagnosis and personalized care.
Call or WhatsApp: +1(267) 388-9828 to schedule your SCN3A Gene Epilepsy Focal NGS Genetic DNA Test and receive comprehensive genetic insights for better neurological health management.
